PRC/PRMS reviews are conducted by three committees. Committees A and B alternate review of therapeutic oncology trials so that one of the committees meets every two weeks to ensure rapid review of studies and facilitate prompt progression of cancer protocols from the PRC/PRMS to the responsible IRB. Committee C reviews behavioral, cancer epidemiology, cancer control, cancer prevention, and complementary medicine protocols on an ad hoc basis, as needed.
| COMMITTEE A | Specialty |
|---|---|
| Andrew Laman, MD (Chair) | Medical Oncology (Community Physician) |
| Yana Najjar, MD (Vice-Chair) | Hematology/Oncology |
| Yoshio Arai, MD | Radiation Oncology |
| Adam Brufsky, MD, PhD | Hematology/Oncology/Breast |
| David Clump, MD | Radiation Oncology |
| Kathleen Dorritie, MD | Hematology/Oncology |
| Jackie Hahn-Efrati, CCRP | Regulatory Specialist (CRS) |
| Annie Im, MD | Hematology/Oncology |
| Anuradha Krishnamurthy, MD | Hematology/Oncology |
| Jason Luke, MD | Immunotherapeutics/Hematology/Oncology |
| William Maguire, MD | Fellow, Hematology/Oncology |
| Megan Mantica, MD | Neuro-Oncology |
| Gretta Rainey, PharmD | Pharmacist |
| Ashwin Somasundaram, MD | Hematology/Oncology |
| Laura Stabile, PhD | Pharmacology & Chemical Biology |
| Sarah Taylor, MD | Gynecologic Oncology |
| Roby Thomas, MD | Hematology/Oncology |
| Hong Wang, PhD / Shuyan Zhai | Statistician |
| Donald Woytowitz, MD | Hematology/Oncology |
| COMMITTEE B | Specialty |
|---|---|
| Leonard Appleman, MD, PhD (Chair) | Hematology/Oncology |
| Michael Boyiadzis, MD (Vice-Chair) | Hematology/Oncology |
| Anne Blake, RPh | Pharmacist |
| Andrew Bukowinski, MD | Phase I/COG, CHP |
| Melissa Burgess, MD | Hematology/Oncology |
| Diwakar Davar, MD | Hematology/Oncology |
| Rajeev Dhupar, MD | Medicine, Cardiothoracic Surgery |
| William Gooding/ Yongli Shuai | Statistician |
| Udai Kammula, MD | Surgical Oncology |
| Zahra Kelly, DO | Fellow, Hematology/Oncology |
| Chaoyuan Kuang, MD, PhD | Fellow, Hematology/Oncology |
| Frank Lieberman, MD | Neuro-oncology/Medicine |
| Jodi Maranchie, MD | Urology |
| Brieana Marino, MA | Regulatory Manager (CRS) |
| Dhaval Mehta, MD | Hematology/Oncology |
| Adam Olson, MD | Radiation Oncology |
| Linda Robertson, DrPH, RN, MSN | Hematology/Oncology – Multiple Myeloma, Immunology |
| John Schmitz, PhD | Faculty, Pharmacokinetics & Pharmacodynamics |
| Liza Villaruz, MD | Hematology/Oncology |
| COMMITTEE C | Specialty |
|---|---|
| Linda Robertson, DrPH, RN, MSN (Chair) | Associate Director, Health Equity, Education and Advocacy |
| Jian-Min Yuan, MD, PhD (Vice-Chair) | Cancer Epidemiology and Prevention Control |
| Catherine Bender, PhD, RN | Professor, Nursing & CTSI |
| Dana Bovbjerg, PhD | Biobehavioral Cancer Control Program |
| Karen Holeva, BS | Manager, Radiation Oncology Research |
| Donna Posluszny, PhD | Asst. Professor, Behavioral Medicine Clinical Service |
| Shuyan Zhai, PhD | Biostatistician |
| Alternates (A/B) | Specialty |
|---|---|
| Tullia Bruno, MD | Immunology/Immunotherapy |
| Timothy Burns, MD | Hematology/Oncology |
| Jeffrey Goff / Brian Miller | Pharmacy |
| Adrian Lee, PhD | Pharmacology and Chemical Biology |
| Peter Lucas, MD, PhD | Translational Pathology, Biology and Pediatrics |
| Yuri Nikiforov, MD, PhD | Molecular and Genomic Pathology |
| Robert Redner, MD | Hematology/Oncology |
| Margaret Rosenzweig, PhD | Oncology, Acute Care Nurse Practitioner Program (Pitt) |
| Heath Skinner, MD, PhD | Genome Stability / Radiation Oncology |
